| Stocks Press Releases + Feed Topics Locations Industries DatesPremium Press Releases | Show All
 | By CorporateAds October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential
|  | By CorporateAds New Meta META Reseller Status, Expanding Consumer Demand and Emerging Applications Across Humanoid Robotics, Military Training and Healthcare Position Virtuix $VTIX at the Intersection of Immersive Technology and Next-Generation Innovation
|  | By CorporateAds From "Diagnose and Treat" to "Predict, Alert and Intervene"—POMDOCTOR $POM. New AI-Powered Predictive Healthcare Vision Takes Center Stage in October 12 Announcement.
|  | By CorporateAds New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.
|  | By CorporateAds Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline
|  | By CorporateAds From AI-Powered Chronic Disease Management to "Hardware + AI + Payment," POMDOCTOR Is Building a Broader Digital Healthcare Infrastructure Platform
|  | By CorporateAds As fentanyl continues to drive an enormous public-health challenge in the United States, Nutriband's AVERSA™ technology is being developed to address a different but important piece of the problem: abuse, misuse, diversion and accidental exposure...
|  | By CorporateAds Today's air-permit approval and immediate Eagle Springs restart mark a major operational milestone, while 5,000-barrel-per-day capacity, 15,000 barrels of crude inventory, Nevada oil-development plans and a tightening Western refining market put Sky...
|  | By CorporateAds Cycurion, Inc. (N A S D A Q: CYCU) Expands From Government Cybersecurity Into Public Safety, Healthcare, AI, Fleet Analytics and Commercial Markets as Q2 Margins Surge Nearly 5X and Management Authorizes $500K Share Repurchases
|  | By CorporateAds $NTRB reaches a new 52-week high of $9.00 and closes at $8.99, extending a powerful September advance as the company approaches the September 30 expiration of 910,904 publicly traded warrants and continues advancing its AVERSA™ abuse-deterrent...
|  | By CorporateAds Today's Proposed Combination Could Significantly Expand CDIX's Healthcare Footprint — While New Equity, Warrants and Exercise Activity Put the Capital Structure Squarely in Focus
|  | By CorporateAds New worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's platform, creating a potential path from patient subtypes and biomarkers to biological mechanisms and therapeutic targets.
|  | By CorporateAds With $NTRB shares gaining significant momentum in September, investors are watching a rapidly approaching warrant expiration, new intellectual-property progress for Nutriband's abuse-deterrent fentanyl platform, strengthening visibility through Nasdaq's..
|  | By CorporateAds With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts
|  | By CorporateAds Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to...
|  | By CorporateAds NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...
|  | By CorporateAds With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.
|  | By CorporateAds With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting..
|  | By CorporateAds Strategic Appointments Bring Decades of U.S. Military and Government Experience to (NAS DAQ: ASTI) $ASTI as NASA-Related Testing, MEO/GEO Qualification, Spacecraft Deployments, Drones, HAPS and Autonomous Systems Expand the Company's Commercial...
|  | By CorporateAds ~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation
|
All Press Releases
 | By CorporateAds October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential
|  | By CorporateAds New Meta META Reseller Status, Expanding Consumer Demand and Emerging Applications Across Humanoid Robotics, Military Training and Healthcare Position Virtuix $VTIX at the Intersection of Immersive Technology and Next-Generation Innovation
|  | By CorporateAds From "Diagnose and Treat" to "Predict, Alert and Intervene"—POMDOCTOR $POM. New AI-Powered Predictive Healthcare Vision Takes Center Stage in October 12 Announcement.
|  | By CorporateAds New SmallCapVoice interview with $SKYQ puts the spotlight on a restarted Nevada refinery, 5,000-barrel-per-day potential, a non-dilutive $50 million oil-development initiative and Sky Quarry's plans to ramp both Nevada and Utah operations.
| By Filmdemand FilmDemand Productions has opened its accredited investor capital raise for The Violinist, a prestige Eastern European crime drama set in Chicago, as private capital increasingly seeks alternative pathways into film financing and lawmakers advance...
|  | By CorporateAds Today's landmark defense contract launches the FDA-approved SPARC-TMS trial while NRx simultaneously advances its preservative-free ketamine program, HOPE Therapeutics and an expanding CNS pipeline
|  | By CorporateAds From AI-Powered Chronic Disease Management to "Hardware + AI + Payment," POMDOCTOR Is Building a Broader Digital Healthcare Infrastructure Platform
|  | By CorporateAds As fentanyl continues to drive an enormous public-health challenge in the United States, Nutriband's AVERSA™ technology is being developed to address a different but important piece of the problem: abuse, misuse, diversion and accidental exposure...
|  | By CorporateAds Today's air-permit approval and immediate Eagle Springs restart mark a major operational milestone, while 5,000-barrel-per-day capacity, 15,000 barrels of crude inventory, Nevada oil-development plans and a tightening Western refining market put Sky...
|  | By CorporateAds Cycurion, Inc. (N A S D A Q: CYCU) Expands From Government Cybersecurity Into Public Safety, Healthcare, AI, Fleet Analytics and Commercial Markets as Q2 Margins Surge Nearly 5X and Management Authorizes $500K Share Repurchases
|  | By CorporateAds $NTRB reaches a new 52-week high of $9.00 and closes at $8.99, extending a powerful September advance as the company approaches the September 30 expiration of 910,904 publicly traded warrants and continues advancing its AVERSA™ abuse-deterrent...
|  | By CorporateAds Today's Proposed Combination Could Significantly Expand CDIX's Healthcare Footprint — While New Equity, Warrants and Exercise Activity Put the Capital Structure Squarely in Focus
|  | By CorporateAds New worldwide agreement adds human cellular validation to Lunai's AI-driven Parkinson's platform, creating a potential path from patient subtypes and biomarkers to biological mechanisms and therapeutic targets.
|  | By CorporateAds With $NTRB shares gaining significant momentum in September, investors are watching a rapidly approaching warrant expiration, new intellectual-property progress for Nutriband's abuse-deterrent fentanyl platform, strengthening visibility through Nasdaq's..
|  | By CorporateAds With a potential Q4 commercial launch, expanding diagnostic opportunities, a major telehealth platform, veterinary oncology initiatives and a proposed Xycota acquisition, NexTel is positioning $MAJI around multiple potential growth catalysts
|  | By CorporateAds Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to...
|  | By CorporateAds NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026...
|  | By CorporateAds With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S.
|  | By CorporateAds With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting..
|  | By CorporateAds Strategic Appointments Bring Decades of U.S. Military and Government Experience to (NAS DAQ: ASTI) $ASTI as NASA-Related Testing, MEO/GEO Qualification, Spacecraft Deployments, Drones, HAPS and Autonomous Systems Expand the Company's Commercial...
|  | By CorporateAds ~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation
|  | By Technology Labs, LLC | StockResearch AI StockResearch AI Initiates Coverage on Apple With New Report Examining Valuation, AI Strategy and Future Growth
|  | By CorporateAds Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.
|  | By CorporateAds With NASA testing demonstrating potential radiation self-annealing in ASTI's CIGS technology, the Company is now expanding its validation program beyond Low Earth Orbit as demand grows for lightweight, resilient solar solutions for space-based power,...
|  | By CorporateAds Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.
|  | By CorporateAds Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide
|  | By CorporateAds MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031
|  | By CorporateAds First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
|  | By CorporateAds Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
|  | By CorporateAds Latest Commercial Wins Highlight Expanding Demand for Ascent's Lightweight Thin-Film Solar Technology Across Space, Defense, High-Altitude Platforms, Drones and Autonomous Marine Systems While Reinforcing the Company's Primary Focus on the Fast-Growing...
|  | By CorporateAds Leading Innovators in the Emerging AUV/Drone Sector Include ZenaTech (N A S D A Q: ZENA) $ZENA, Draganfly (N A S D A Q: DPRO) $DRPO, Quantum Cyber N.V. (N A S D A Q: QUCY) $QUCY, Unusual Machines, (N YS E American: UMAC) $UMAC, Safe Pro Group Inc.
|
Page: 1 2 NextPage updated every 10 minutes
| |